KUNKEL LORI ANNE sold 19.3% of their position (10K shares) of ENLIVEN THERAPEUTICS, INC. on the open market
Open‑market sale worth $504.9K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 7/8/2026ACC: 0001536368-26-000007
Director
Since Feb 2026
-10K
Net shares
Net seller
$504.9K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
10K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−4.11K
Price / share
$49.98
Trade value
$205.48K
% of position
7.9%
7/6/2026
51.88K→47.77K
Common Stock
Direct
Shares
−5.89K
Price / share
$50.84
Trade value
$299.42K
% of position
12.3%
7/6/2026
47.77K→41.88K
Total
Net shares
−10K
Net value
-$504.90K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/6/2026 | S · Sale | −4.11K | $49.98 | $205.48K | 7.9% | 51.88K | 47.77K |
| Common Stock Direct | 7/6/2026 | S · Sale | −5.89K | $50.84 | $299.42K | 12.3% | 47.77K | 41.88K |
| Total | −10K | -$504.90K | ||||||
Derivative Transactions0
No derivative transactions reported